Sinopharm unit's Covid vaccine secures approval for use on minors in China
The vaccine from Sinopharm unit Beijing Institute of Biological Products obtained approval to be used on people aged between three and 17. Doses of the Chinese Sinopharm vaccine against the coronavirus disease are seen at the Biblioteka kod Milutina restaurant in Kragujevac, Serbia, May 4, 2021. Reuters
A Covid-19 vaccine from Sinopharm unit Beijing Institute of Biological Products has obtained approval to be used on people aged between three and 17 in China, a disease control official said on Friday.
Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, was speaking to reporters at a news briefing.
22.12°C Kathmandu
.jpg&w=300&height=200)
